MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Cash from Operations came in at 46631000.0 in Q4 2025, up 300.34% YoY from 11647866.63 in Q4 2024, and up 481.75% on a QoQ basis from 12215000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Cash from Operations data on file, last reported at 46631000.0 in Q4 2025.
- Quarterly Cash from Operations rose 300.34% year-over-year to 46631000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 46359000.0 (up 55.64% YoY) and the FY2025 annual result came in at 46359000.0, up 55.64% from the prior year.
- Cash from Operations improved to 46631000.0 in Q4 2025, from 12215000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 46631000.0 in Q4 2025 to a low of 43975000.0 in Q2 2025.
- A 5-year average of 16992350.0 and a median of 20993500.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations plunged 350.61% — and 2025, when it jumped 300.34%.
- Tracing MGTX's Cash from Operations over 5 years: stood at 18828000.0 in 2021, then sank by 186.4% to 16267000.0 in 2022, then rose by 10.57% to 14547000.0 in 2023, then slumped by 60.01% to 23276000.0 in 2024, then jumped by 300.34% to 46631000.0 in 2025.
- The last three Cash from Operations figures came in at 46631000.0 (Q4 2025), 12215000.0 (Q3 2025), and 43975000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 46.60 Mn |
| Sep 30, 2025 | -12.23 Mn |
| Jun 30, 2025 | -43.95 Mn |
| Mar 31, 2025 | -36.83 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Sep 30, 2024 | -25.02 Mn |
| Jun 30, 2024 | -19.46 Mn |
| Mar 31, 2024 | -36.74 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Sep 30, 2023 | -24.41 Mn |
| Jun 30, 2023 | -29.01 Mn |
| Mar 31, 2023 | -37.39 Mn |
| Dec 31, 2022 | -16.27 Mn |
| Sep 30, 2022 | -20.73 Mn |
| Jun 30, 2022 | -27.81 Mn |
| Mar 31, 2022 | -8.30 Mn |
| Dec 31, 2021 | 18.83 Mn |
| Sep 30, 2021 | -17.18 Mn |
| Jun 30, 2021 | -21.26 Mn |
| Mar 31, 2021 | 9.09 Mn |